Cite
Semitala FC, Musinguzi A, Ssemata J, et al. Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda-patient and health worker perspectives. Implement Sci Commun. 2021;2(1):71doi: 10.1186/s43058-021-00173-2.
Semitala, F. C., Musinguzi, A., Ssemata, J., Welishe, F., Nabunje, J., Kadota, J. L., Berger, C. A., Katamba, A., Kiwanuka, N., Kamya, M. R., Dowdy, D., Cattamanchi, A., & Katahoire, A. R. (2021). Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda-patient and health worker perspectives. Implementation science communications, 2(1), 71. https://doi.org/10.1186/s43058-021-00173-2
Semitala, Fred C, et al. "Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda-patient and health worker perspectives." Implementation science communications vol. 2,1 (2021): 71. doi: https://doi.org/10.1186/s43058-021-00173-2
Semitala FC, Musinguzi A, Ssemata J, Welishe F, Nabunje J, Kadota JL, Berger CA, Katamba A, Kiwanuka N, Kamya MR, Dowdy D, Cattamanchi A, Katahoire AR. Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda-patient and health worker perspectives. Implement Sci Commun. 2021 Jun 30;2(1):71. doi: 10.1186/s43058-021-00173-2. PMID: 34193311; PMCID: PMC8247167.
Copy
Download .nbib